Chemical materials

Robatumumab (anti-IGF1R)

Robatumumab (anti-IGF1R)

AL-AB183430 / 1MG
CAS No.:934235-44-6
Add to Inquiry
Robatumumab (anti-IGF1R)

Robatumumab (anti-IGF1R)

AL-AB183430 / 5MG
CAS No.:934235-44-6
Add to Inquiry
Robatumumab (anti-IGF1R)

Robatumumab (anti-IGF1R)

AL-AB183430 / 10MG
CAS No.:934235-44-6
Add to Inquiry
Robatumumab (anti-IGF1R)

Robatumumab (anti-IGF1R)

AL-AB183430 / 100ΜG
CAS No.:934235-44-6
Add to Inquiry
Samalizumab (anti-CD200)

Samalizumab (anti-CD200)

AL-AB183431 / 100ΜG
CAS No.:1073059-33-2
Add to Inquiry
Samalizumab (anti-CD200)

Samalizumab (anti-CD200)

AL-AB183431 / 10MG
CAS No.:1073059-33-2
Add to Inquiry
Samalizumab (anti-CD200)

Samalizumab (anti-CD200)

AL-AB183431 / 1MG
CAS No.:1073059-33-2
Add to Inquiry
Samalizumab (anti-CD200)

Samalizumab (anti-CD200)

AL-AB183431 / 5MG
CAS No.:1073059-33-2
Add to Inquiry
Tadocizumab (anti-Integrin α2β3)

Tadocizumab (anti-Integrin α2β3)

AL-AB183432 / 1MG
CAS No.:339086-80-5
Add to Inquiry
Tadocizumab (anti-Integrin α2β3)

Tadocizumab (anti-Integrin α2β3)

AL-AB183432 / 5MG
CAS No.:339086-80-5
Add to Inquiry
Tadocizumab (anti-Integrin α2β3)

Tadocizumab (anti-Integrin α2β3)

AL-AB183432 / 10MG
CAS No.:339086-80-5
Add to Inquiry
Tadocizumab (anti-Integrin α2β3)

Tadocizumab (anti-Integrin α2β3)

AL-AB183432 / 100ΜG
CAS No.:339086-80-5
Add to Inquiry
Tenatumomab (anti-Tenascin C)

Tenatumomab (anti-Tenascin C)

AL-AB183433 / 10MG
CAS No.:1412891-40-7
Add to Inquiry
Tenatumomab (anti-Tenascin C)

Tenatumomab (anti-Tenascin C)

AL-AB183433 / 5MG
CAS No.:1412891-40-7
Add to Inquiry
Tenatumomab (anti-Tenascin C)

Tenatumomab (anti-Tenascin C)

AL-AB183433 / 1MG
CAS No.:1412891-40-7
Add to Inquiry
Tenatumomab (anti-Tenascin C)

Tenatumomab (anti-Tenascin C)

AL-AB183433 / 100ΜG
CAS No.:1412891-40-7
Add to Inquiry
Vesencumab (anti-NRP1)

Vesencumab (anti-NRP1)

AL-AB183435 / 100ΜG
CAS No.:1205533-60-3
Add to Inquiry
Vesencumab (anti-NRP1)

Vesencumab (anti-NRP1)

AL-AB183435 / 1MG
CAS No.:1205533-60-3
Add to Inquiry
Vesencumab (anti-NRP1)

Vesencumab (anti-NRP1)

AL-AB183435 / 5MG
CAS No.:1205533-60-3
Add to Inquiry
Vesencumab (anti-NRP1)

Vesencumab (anti-NRP1)

AL-AB183435 / 10MG
CAS No.:1205533-60-3
Add to Inquiry
Zalutumumab (anti-EGFR)

Zalutumumab (anti-EGFR)

AL-AB183436 / 1MG
CAS No.:667901-13-5
Add to Inquiry
Zalutumumab (anti-EGFR)

Zalutumumab (anti-EGFR)

AL-AB183436 / 5MG
CAS No.:667901-13-5
Add to Inquiry
Zalutumumab (anti-EGFR)

Zalutumumab (anti-EGFR)

AL-AB183436 / 10MG
CAS No.:667901-13-5
Add to Inquiry
Zalutumumab (anti-EGFR)

Zalutumumab (anti-EGFR)

AL-AB183436 / 100ΜG
CAS No.:667901-13-5
Add to Inquiry
Matuzumab (anti-EGFR)

Matuzumab (anti-EGFR)

AL-AB183438 / 10MG
CAS No.:339186-68-4
Add to Inquiry
Matuzumab (anti-EGFR)

Matuzumab (anti-EGFR)

AL-AB183438 / 5MG
CAS No.:339186-68-4
Add to Inquiry
Matuzumab (anti-EGFR)

Matuzumab (anti-EGFR)

AL-AB183438 / 1MG
CAS No.:339186-68-4
Add to Inquiry
Matuzumab (anti-EGFR)

Matuzumab (anti-EGFR)

AL-AB183438 / 100ΜG
CAS No.:339186-68-4
Add to Inquiry
Teneliximab (anti-CD40)

Teneliximab (anti-CD40)

AL-AB183440 / 10MG
CAS No.:299423-37-3
Add to Inquiry
Teneliximab (anti-CD40)

Teneliximab (anti-CD40)

AL-AB183440 / 5MG
CAS No.:299423-37-3
Add to Inquiry
Teneliximab (anti-CD40)

Teneliximab (anti-CD40)

AL-AB183440 / 1MG
CAS No.:299423-37-3
Add to Inquiry
Teneliximab (anti-CD40)

Teneliximab (anti-CD40)

AL-AB183440 / 100ΜG
CAS No.:299423-37-3
Add to Inquiry
Faralimomab (anti-IFNAR-1)

Faralimomab (anti-IFNAR-1)

AL-AB183441 / 10MG
CAS No.:167816-91-3
Add to Inquiry
Faralimomab (anti-IFNAR-1)

Faralimomab (anti-IFNAR-1)

AL-AB183441 / 5MG
CAS No.:167816-91-3
Add to Inquiry
Faralimomab (anti-IFNAR-1)

Faralimomab (anti-IFNAR-1)

AL-AB183441 / 1MG
CAS No.:167816-91-3
Add to Inquiry
Faralimomab (anti-IFNAR-1)

Faralimomab (anti-IFNAR-1)

AL-AB183441 / 100ΜG
CAS No.:167816-91-3
Add to Inquiry
Metelimumab (anti-TGFb1)

Metelimumab (anti-TGFb1)

AL-AB183442 / 1MG
CAS No.:272780-74-2
Add to Inquiry
Metelimumab (anti-TGFb1)

Metelimumab (anti-TGFb1)

AL-AB183442 / 5MG
CAS No.:272780-74-2
Add to Inquiry
Metelimumab (anti-TGFb1)

Metelimumab (anti-TGFb1)

AL-AB183442 / 10MG
CAS No.:272780-74-2
Add to Inquiry
Metelimumab (anti-TGFb1)

Metelimumab (anti-TGFb1)

AL-AB183442 / 100ΜG
CAS No.:272780-74-2
Add to Inquiry
Mapatumumab (anti-TNFRSF10A)

Mapatumumab (anti-TNFRSF10A)

AL-AB183444 / 100ΜG
CAS No.:658052-09-6
Add to Inquiry
Mapatumumab (anti-TNFRSF10A)

Mapatumumab (anti-TNFRSF10A)

AL-AB183444 / 5MG
CAS No.:658052-09-6
Add to Inquiry
Mapatumumab (anti-TNFRSF10A)

Mapatumumab (anti-TNFRSF10A)

AL-AB183444 / 1MG
CAS No.:658052-09-6
Add to Inquiry
Mapatumumab (anti-TNFRSF10A)

Mapatumumab (anti-TNFRSF10A)

AL-AB183444 / 10MG
CAS No.:658052-09-6
Add to Inquiry
Toralizumab (anti-CD40L)

Toralizumab (anti-CD40L)

AL-AB183447 / 100ΜG
CAS No.:252662-47-8
Add to Inquiry
Toralizumab (anti-CD40L)

Toralizumab (anti-CD40L)

AL-AB183447 / 10MG
CAS No.:252662-47-8
Add to Inquiry
Toralizumab (anti-CD40L)

Toralizumab (anti-CD40L)

AL-AB183447 / 5MG
CAS No.:252662-47-8
Add to Inquiry
Toralizumab (anti-CD40L)

Toralizumab (anti-CD40L)

AL-AB183447 / 1MG
CAS No.:252662-47-8
Add to Inquiry
Ruplizumab (anti-CD40L)

Ruplizumab (anti-CD40L)

AL-AB183448 / 1MG
CAS No.:220651-94-5
Add to Inquiry
Ruplizumab (anti-CD40L)

Ruplizumab (anti-CD40L)

AL-AB183448 / 100ΜG
CAS No.:220651-94-5
Add to Inquiry
LOCATIONS

Service location

Taipei, New Taipei, Keelung / Yilan / Hualien
Inquiry Cart

Your inquiry Cart total 0 items

In accordance with the EU General Data Protection Regulation, we are committed to protecting your personal data and providing you with control over your personal data.
By clicking "Accept All," you allow us to place cookies to enhance your experience on this website, help us analyze website performance and usage, and enable us to deliver relevant marketing content. You can manage your cookie settings below. Clicking "Confirm" means you agree to the current settings.
Manage Cookies

Privacy Preference Center

In accordance with the EU General Data Protection Regulation, we are committed to protecting your personal data and providing you with control over your personal data.
By clicking "Accept All," you allow us to place cookies to enhance your experience on this website, help us analyze website performance and usage, and enable us to deliver relevant marketing content. You can manage your cookie settings below. Clicking "Confirm" means you agree to the current settings.
View Privacy Policy

Manage Consent Settings

Necessary Cookies

Enable all
The operation of the website relies on these cookies, and you cannot disable them in the system. These cookies are usually set based on the actions you take (i.e., service requests), such as setting privacy preferences, logging in, or filling out forms. You can set your browser to block or prompt you about these cookies, but this may cause some website functions to stop working.